Who has more life? Authentic bodies and the ethopolitics of stem cells

Configurations

Volumn 16, Issue 3, 2008, Pages 379-398

  Langstrup, Henriette ^a   Sommerlund, Julie ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Danish Design School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949280043     PISSN: 10631801     EISSN: 10806520     Source Type: Journal    
DOI: 10.1353/con.0.0061     Document Type: Article

References (58)

1. The Missouri Stem Cell and Cure Initiative, "Joan's Story." 2006. http://video.google.com/videoplay?docid=6616198448243556634.
2. We take as a starting point U.S. president George W. Bush's 2001 statement introducing the American public to his reflection on hESC research and his decision to allow publicly funded research only for already-existing stem-cell lines derived from hESC, while prohibiting further public funding for hESC research in which embryos would be destroyed. Our empirical material has been collected primarily through Internet sources, but should not be seen as an exhaustive mapping of the ongoing mobilization of representations in the stem-cell controversy, which spans continents and involves an array of different people and organizations and even different controversies. Our objective is to point to some specific forms of representations-a taxonomy of embodied representation-which seem to be more potent than others when issues of "life itself" is put up for public debate.
3. C. Williams, J. Kitzinger, and L. Henderson, "Envisaging the Embryo in Stem Cell Research: Rhetorical Strategies and Media Reporting of the Ethical Debates," Sociology of Health & Illness 25:7 (2003): 793-814.
4. M. C. Nisbet, D. Brossard, and A. Kroepsch, "Framing Science: The Stem Cell Controversy in an Age of Press/Politics," Press/Politics 8:2 (2003): 36-70.
5. B. A. McCloskey, "The Controversy Surrounding Stem Cell Research," Policy, Politics, & Nursing Practice 3:1 (2002): 4-13.
6. N. Rose, "The Politics of Life Itself," Theory, Culture & Society 18:6 (2001): 1-30
7. and N. Rose, The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century (Princeton, NJ: Princeton University Press, 2007).
8. Rose, "Politics of Life Itself" (above, n. 6).
9. Rose, "Politics of Life Itself" Ibid.
10. Rose, "Politics of Life Itself" Ibid., p. 18.
11. ©-Meets- OncoMouse™ (New York: Routledge, 1997).
12. Rose, "Politics of Life Itself" (above, n. 6);
13. C. Novas and N. Rose, "Genetic Risk and the Birth of the Somatic Individual," Economy and Society 29:4 (2000): 485-513.
14. P. Brown, S. Zavestoski, S. McCormick, B. Mayer, R. Morello-Frosch, and R. G. Altman, "Embodied Health Movements: New Approaches to Social Movements in Health," Sociology of Health & Illness 26:1 (2004)
15. S. Epstein, Impure Science: AIDS, Activism, and the Politics of Knowledge (Berkeley: University of California Press, 1996)
16. M. G. Good, "The Biotechnical Embrace," Culture, Medicine and Psychiatry 25 (2001): 395-410
17. V. Rabeharisoa and M. Callon, "Patients and Scientists: French Muscular Dystrophy Research," in States of Knowledge, ed. S. Jasanoff (London: Routledge, 2004).
18. Rose, "Politics of Life Itself" (above, n. 6), p. 22.
19. Novas and Rose, "Genetic Risk" (above, n. 11).
20. C. Thompson, Making Parents: The Ontological Choreography of Reproductive Technologies (Cambridge, MA: MIT Press, 2005), p. 247.
21. The White House (2001), in M. Ruse and C. A. Pynes, eds., The Stem Cell Controversy (New York, Prometheus Books, 2003).
22. The White House (2001), The Stem Cell Controversy, 2003, Ibid., pp. 10.
23. The White House (2001), The Stem Cell Controversy, 2003, Ibid., pp. 10.
24. The White House (2001), The Stem Cell Controversy, 2003, Ibid., pp. 10.
25. S. M. Squier, Liminal Lives: Imagining the Human at the Frontiers of Biomedicine (Durham, NC: Duke University Press, 2004);
26. see also www.nightlight.org.
27. Squier, Liminal Lives (above, n. 20).
28. Quoted in L. Haines, "Bush Pledges to Veto Stem Cell Bill," Register. 2005. http://www.theregister.co.uk/2005/05/23/bush-bill-veto/.
29. L. Haines, "Bush Pledges to Veto Stem Cell Bill," Register. 2005. Ibid.
30. S. G. Stolberg, "House Approves a Stem Cell Research Bill Opposed by Bush," New York Times, May 25, 2005.
31. For an example from the UK setting, see Williams, Kitzinger, and Henderson, "Envisaging the Embryo" (above, n. 3).
32. Wall Street Journal, March 31, 2004 quoted in the JDRF's website (www.jdrf.org).
33. JDRF, "Help Us Find a Cure," in Countdown for Kids. 2005. www.jdrf.org.
34. See http://www.youtube.com/watch?v=XMhU0gDvYYw.
35. N. Brown and M. Michael, "From Authority to Authenticity: The Changing Governance of Biotechnology," Health, Risk & Society 4:3 (2002): 259-272.
36. N. Brown and M. Michael, "From Authority to Authenticity: The Changing Governance of Biotechnology," Health, Risk & Society 4:3 (2002): Ibid., p. 259.
37. T. Moreira and P. Palladino, "Between Truth and Hope: On Parkinson's Disease, Neurotransplantation, and the Production of the 'Self,'" History of the Human Sciences 18:3 (2005): 55-82, quote on 74.
38. Haraway, Modest-Witness (above, n. 10).
39. Moreira and Palladino, "Between Truth and Hope" (above, n. 31).
40. L. Berlant, "The Subject of True Feeling: Pain, Privacy, and Politics," in Transformations: Thinking Through Feminism, ed. S. Ahmed, J. Kilby, C. Lury, M. McNeil, and B. Skeggs (pp. 33-47) (New York: Routledge, 2000).
41. R. Reagan, "Ron Reagan Speaks at the Democratic Convention." 2004. www.dems2004.org.
42. C. Seale, D. Cavers, and M. Dixon-Woods, "Commodification of Body Parts: By Medicine or by Media?" Body and Society 12:1 (2006): 25-42.
43. Media Matters for America, "On Michael J. Fox and R. Limbaugh." 2006. http://mediamatters.org/items/200610270019.
44. E. Scarry, The Body in Pain (New York: Oxford University Press, 1985), p. 4.
45. D. Montgomery, "Rush Limbaugh on the Offensive Against Ad with Michael J. Fox," Washington Post, October 25, 2006.
46. R. Barthes, Mytologier (1957; reprint, København: Nordisk Forlag).
47. C. Metz, The Imaginary Signifier (Bloomington: Indiana University Press, 1982).
48. R. Dyer, Stars (London: BFI Publishing, 1979), p. 35.
49. R. Dyer, Stars, 1979, p. 35 Ibid.
50. J. Gamson, Claims to Fame: Celebrity in Contemporary America (Berkeley: University of California Press, 1994).
51. B. M. Thomsen, Filmdivaer (København: Museum Tuscalanums Forlag, 1997), p. 20 (our translation).
52. Scarry, Body in Pain (above, n. 38).
53. N. Brown, "Hope Against Hype: Accountability in Biopasts, Presents, and Futures," Science Studies 16:2 (2003): 3-21
54. Brown and Michael, From Authority to Authenticity" (above, n. 29);
55. N. Brown and M. Michael, "A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects," Technology Analysis & Strategic Management 15:1 (2003), 3-18.
56. S. Ahmed and J. Stacey, "Testimonial Cultures: An Introduction," Cultural Values 5:1 (2001): 1-6
57. see also C. Novas and F. Lentzos, "Marketing Disease, Drugs, ConditionBranding and Celebrity," BIOS Centre, LSE, London. http://www.lse.ac.uk/collections/BIOS/.
58. M. Serres, Rome: The Book of Foundations (Stanford, CA: Stanford University Press, 1991).